Pharmacodynamic and safety study of reolysin in patients with advanced solid tumors

被引：0
|
作者：
Gollamudi, R.
Desai, K.
Chaudhary, I.
Ghalib, M. H.
Wong, B.
Einstein, M.
Coffey, M.
Gill, G.
Mani, S.
Goel, S.
机构：
[1] Montefiore Albert Einstein Canc Ctr, Bronx, NY USA
[2] Oncolyt Biotech Inc, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14004
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors
    Fakih, Marwan G.
    Trump, Donald L.
    Muindi, Josephia R.
    Black, Jennifer D.
    Bernardi, Ronald J.
    Creaven, Patrick J.
    Schwartz, James
    Brattain, Michael G.
    French, Renee
    Johnson, Candance S.
    CLINICAL CANCER RESEARCH, 2007, 13 (04) : 1216 - 1223
  • [32] A pharmacodynamic pilot study of DS8201a in patients with HER2 expressing advanced solid tumors
    Shin, Sarah J.
    -Coyne, Geraldine O'Sullivan
    Lee, Elizabeth K.
    Mittra, Arjun
    Sternberg, Cora N.
    Ong, Mary Jane
    Wilsker, Deborah
    Ferry-Galow, Katherine
    Foster, Jared
    Juwara, Lamin
    Takebe, Naoko
    Pickett, Cheryl A.
    Parchment, Ralph
    Doroshow, James
    Chen, Alice
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [33] Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
    D Alan Anthoney
    Jay Naik
    Iain RJ MacPherson
    Donna Crawford
    John M Hartley
    Janet A Hartley
    Tomohisa Saito
    Masaichi Abe
    Keith Jones
    Masanori Miwa
    Christopher Twelves
    TRJ Evans
    BMC Cancer, 12
  • [34] Pharmacokinetic and pharmacodynamic study of the combination of docetaxel and topotecan in patients with solid tumors
    Zamboni, WC
    Egorin, MJ
    Van Echo, DA
    Day, RS
    Meisenberg, BR
    Brooks, SE
    Doyle, LA
    Nemieboka, NN
    Dobson, JM
    Tait, NS
    Tkaczuk, KH
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3288 - 3294
  • [35] A phase I study of the safety and pharmacodynamic effects of everolimus in combination with lenalidomide in patients with advanced solid malignancies.
    Owonikoko, Taofeek Kunle
    Harvey, R. Donald
    Kauh, John S.
    Lewis, Colleen Margaret
    Hossain, Mohammed S.
    Akintayo, Adebowale O.
    Merriewether, A. Rene
    Chen, Zhengjia
    Hawk, Natalyn Nicole
    Saba, Nabil F.
    Harris, Wayne
    Shin, Dong Moon
    El-Rayes, Bassel F.
    Huang, Chunzi
    Lonial, Sagar
    Lawson, David H.
    Khuri, Fadlo Raja
    Waller, Edmund K.
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] A safety and tolerability study of vadimezan in combination with docetaxel in Japanese patients with advanced or recurrent solid tumors
    Hida, T.
    Takeda, K.
    Daga, H.
    Ishikawa, S.
    Shimizu, J.
    Tokunaga, S.
    Horio, Y.
    Ito, K.
    Kobayashi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors
    Bendell, Johanna C.
    Patel, Manish R.
    Yoshida, Kenichiro
    Seraj, Jabed
    Weaver, Racquel
    Lemech, Charlotte
    Todaro, Thomas G.
    Pant, Shubham
    Arkenau, Hendrik-Tobias
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1275 - 1283
  • [38] Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
    Markman, B.
    Tabernero, J.
    Krop, I.
    Shapiro, G. I.
    Siu, L.
    Chen, L. C.
    Mita, M.
    Cuero, M. Melendez
    Stutvoet, S.
    Birle, D.
    Anak, Oe.
    Hackl, W.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2399 - 2408
  • [39] Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors
    Johanna C. Bendell
    Manish R. Patel
    Kenichiro Yoshida
    Jabed Seraj
    Racquel Weaver
    Charlotte Lemech
    Thomas G. Todaro
    Shubham Pant
    Hendrik-Tobias Arkenau
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1275 - 1283
  • [40] A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors
    Traynor, Anne M.
    Gordon, Michael S.
    Alberti, Dona
    Mendelson, David S.
    Munsey, Mark S.
    Wilding, George
    Gammans, Richard E.
    Read, William L.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (04) : 509 - 515
12345